P2RX7 and psoriasis: In human skin explants, the pharmacological stimulation of P2X7 with the potent pharmacological agonist BzATP, induced a significant increase in vascular endothelial growth factor (VEGF), IL-23 and IL-6 expression, suggesting that P2X7 activation may be an initiating factor in psoriasis development [117].